The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
BRCA1, RAP80, and AEG-1 mRNA expression in resectable muscle-invasive bladder cancer (MIBC) patients (p) treated with neoadjuvant cisplatin-based chemotherapy.
Albert Font Pous
No relevant relationships to disclose
Pamela Celiz
No relevant relationships to disclose
Miquel Taron
No relevant relationships to disclose
Iman Chaib
No relevant relationships to disclose
Jose Luis Gago
No relevant relationships to disclose
Pedro Mendez
No relevant relationships to disclose
Jose Javier Sanchez
No relevant relationships to disclose
Olatz Etxaniz
No relevant relationships to disclose
Luis Cechini
No relevant relationships to disclose
Nuria Pardo
No relevant relationships to disclose
Belen Sanchez
No relevant relationships to disclose
Jose Luis Cuadra
No relevant relationships to disclose
Ivana Valverde
No relevant relationships to disclose
Oscar Buisan
No relevant relationships to disclose
Luis Ibarz
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose